Mark YY Chan

14.0k citations
371 papers · 6.9k · 4 hit papers · h-index 43

Impact in

Papers in

    • Acute Myocardial Infarction Research 53
    • Antiplatelet Therapy and Cardiovascular Diseases 34
    • Atrial Fibrillation Management and Outcomes 24
    • Heart Failure Treatment and Management 16
    • Cardiovascular Function and Risk Factors 14
    • Coronary Interventions and Diagnostics 33

Mark YY Chan

351 papers receiving 6.7k citations

Mark YY Chan's Hit Papers

Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference for Patients With Obesity or Overweight: A Systematic Review, Meta-analysis, and Meta-regression of 47 Randomized Controlled Trials 2025 · 93 citations
930+1+3Years since publication50100150200

Peers

Mark YY Chan
Comparison fields: 5 of 160
  • Geriatrics and Gerontology 345
  • Cardiology and Cardiovascular Medicine 1.8k
  • Internal Medicine 188
  • Endocrinology, Diabetes and Metabolism 547
  • Epidemiology 755
Replace Gary Tse with:
Gary Tse China
Changyu Shen United States
Julio E. Núñez Spain
Susan A. Weston United States
L E R Rohde Brazil
Fabio Pellegrini Italy
Iain B Squire United Kingdom
Arend Mosterd Netherlands
Peter Bramlage Germany
Frans Hendrik Rutten Netherlands
Mark YY Chan relative to Gary Tse China Gary Tse's profile →
Citations per field
00.5×1.6×
Gary Tse · 1×
Citations per year

Countries citing papers authored by Mark YY Chan

Since Specialization
Citations

This map shows the geographic impact of Mark YY Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark YY Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark YY Chan more than expected).

Fields of papers citing papers by Mark YY Chan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark YY Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark YY Chan. The network helps show where Mark YY Chan may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark YY Chan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark YY Chan Line = papers co-authored together Mark YY Chan links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 371 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2005238
2
Global Prevalence and Clinical Characteristics of Metabolic-associated Fatty Liver Disease: A Meta-Analysis and Systematic Review of 10 739 607 Individuals
Hit paper breakdown →
2022213
3 2009191
4
An Observational Data Meta-analysis on the Differences in Prevalence and Risk Factors Between MAFLD vs NAFLD
Hit paper breakdown →
2021186
5
Current and novel biomarkers of thrombotic risk in COVID-19: a Consensus Statement from the International COVID-19 Thrombosis Biomarkers Colloquium
Hit paper breakdown →
2022181
6 2015127
7 2008115
8 2020111
9 2008108
10 2017105
11 201199
12
Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference for Patients With Obesity or Overweight: A Systematic Review, Meta-analysis, and Meta-regression of 47 Randomized Controlled Trials
Hit paper breakdown →
202593
13 200891
14 201791
15 201890
16 201584
17 201083
18 201875
19 202269
20 202066

About Mark YY Chan

Mark YY Chan is a scholar working on Cardiology and Cardiovascular Medicine, Surgery, Geriatrics and Gerontology, Endocrinology, Diabetes and Metabolism and Internal Medicine, having authored 371 papers that have together received 6.9k indexed citations. Recurring topics across this work include Acute Myocardial Infarction Research (53 papers), Antiplatelet Therapy and Cardiovascular Diseases (34 papers), Coronary Interventions and Diagnostics (33 papers), Atrial Fibrillation Management and Outcomes (24 papers), Cardiac Imaging and Diagnostics (24 papers), Diabetes Treatment and Management (16 papers), Heart Failure Treatment and Management (16 papers) and Cardiovascular Function and Risk Factors (14 papers). The work is most often cited by research in Geriatrics and Gerontology (345 citations), Cardiology and Cardiovascular Medicine (1.8k citations), Internal Medicine (188 citations), Endocrinology, Diabetes and Metabolism (547 citations) and Epidemiology (755 citations). Mark YY Chan has collaborated with scholars based in Singapore, United Kingdom and United States. Frequent co-authors include Ching-Hui Sia, Wee Shiong Lim, Chi-Hang Ronald Lee, Huay Cheem Tan, Atreyi Kankanhalli, Nicholas W S Chew, Irene M. Y. Woon, Adrian Fatt-Hoe Low, Richard C. Becker and Cheng Han Ng. Their work appears in journals such as International Journal of Cardiology, European Heart Journal, Journal of the American College of Cardiology, Frontiers in Cardiovascular Medicine and Journal of Thrombosis and Thrombolysis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact